Literature DB >> 8870811

HLA class II is associated with the frequency of glutamic acid decarboxylase M(r) 65,000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus.

A Kasuga1, A Falorni, T Maruyama, Y Ozawa, C E Grubin, K Matsubara, I Takei, T Saruta, A Scheynius, A Lernmark.   

Abstract

Autoantibodies to glutamic acid decarboxylase (GAD65Ab) are common in both caucasian and Japanese patients with insulin-dependent diabetes mellitus (type 1), while the type 1-associated HLA haplotypes differ. In the present study, we analyzed GAD65Ab in relation to HLA-DQ and -DR alleles in Japanese type 1 patients. GAD65Ab were found in 58% short-duration (less than 5 years) type 1, 23% long-duration type 1, 56% slowly progressive type 1, 3% type 2 patients, and 1.7% healthy individuals. In 75 HLA-typed type 1 patients, the GAD65Ab frequency was higher in short-duration patients with DRB1*08 allele (100%, Pc < 0.05). GAD65Ab frequencies in DQB1*0302, DQB1*0303, and DRB1*09-positive, long-duration type 1 patients were lower than those in short-duration type 1 patients (14%, 19%, and 20%, Pc < 0.02 compared with short-duration type 1, 90%, 75%, and 71%, respectively), while the frequency varied less in DQB1*04 individuals (44% and 30% in short- and long-duration type 1 patients, respectively). These findings were also observed among patients with DRB1*04, i.e., the haplotype DRB1*0405-DQB1*0401 showed less variation in frequency of GAD65Ab (44% and 35% in short- and long-duration type 1 patients, respectively), while DRB1*04xx-DQB1*0302 showed lower frequency in long-duration type 1 than short-duration (13% and 100%, respectively). Thus, HLA class II is associated with frequency GAD65Ab, and this association might be affected by disease duration in Japanese type 1 patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870811     DOI: 10.1007/bf00569419

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  25 in total

1.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

2.  High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International Glutamic Acid Decarboxylase Antibody Workshop.

Authors:  R S Schmidli; P G Colman; E Bonifacio; G F Bottazzo; L C Harrison
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

3.  Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.

Authors:  F K Gorus; C L Vandewalle; H Dorchy; P Van Crombrugge; F C Schuit; D G Pipeleers
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

4.  Differential expression of glutamic acid decarboxylase in rat and human islets.

Authors:  J S Petersen; S Russel; M O Marshall; H Kofod; K Buschard; N Cambon; A E Karlsen; E Boel; W A Hagopian; K R Hejnaes
Journal:  Diabetes       Date:  1993-03       Impact factor: 9.461

5.  Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts.

Authors:  P G Colman; R C Nayak; I L Campbell; G S Eisenbarth
Journal:  Diabetes       Date:  1988-05       Impact factor: 9.461

6.  Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  J Seissler; J Amann; L Mauch; H Haubruck; S Wolfahrt; S Bieg; W Richter; R Holl; E Heinze; W Northemann
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Analysis of MHC class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay.

Authors:  T Maruyama; A Shimada; A Kasuga; T Kasatani; Y Ozawa; M Ishii; I Takei; Y Suzuki; A Kobayashi; S Takeda
Journal:  Diabetes Res Clin Pract       Date:  1994-03       Impact factor: 5.602

8.  Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADAB Workshop.

Authors:  R S Schmidli; P G Colman; E Bonifacio
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.

Authors:  A E Karlsen; W A Hagopian; C E Grubin; S Dube; C M Disteche; D A Adler; H Bärmeier; S Mathewes; F J Grant; D Foster; Åke Lernmark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more
  1 in total

1.  Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.

Authors:  T Maruyama; S Oak; T R Hall; J P Banga; E Ortqvist; R A Ettinger; J Endl; C S Hampe
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.